ロード中...

Clinical Outcomes in Carbapenem-Resistant Enterobacteriaceae Infections Treated With Ceftazidime-Avibactam: A Single-Center Observational Study

Introduction Among the several newer beta lactam+beta lactase inhibitors (BL/BLI), ceftazidime-avibactam is the only drug showing activity against OXA-48-like producers. Hence, it is being increasingly used in India to treat infections caused by carbapenem-resistant Enterobacteriaceae (CRE), especia...

詳細記述

保存先:
書誌詳細
出版年:Cureus
主要な著者: Rathish, Balram, Wilson, Arun, Warrier, Anup, Prakash, Shilpa, Babu, Rachana, Joy, Sonya
フォーマット: Artigo
言語:Inglês
出版事項: Cureus 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931974/
https://ncbi.nlm.nih.gov/pubmed/33680621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13081
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!